BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, January 2, 2026
Home » Authors » Anette Breindl

Articles by Anette Breindl

With Unique MOA, HER4 Joins EGFR Family Cancer Targets

Feb. 7, 2013
By Anette Breindl
Studying cancer cells that survive chemotherapy treatment, scientists from Roche AG subsidiary Genentech Inc. have implicated a member of the human epidermal growth factor receptor, or HER, family in such treatment resistance.
Read More

Sirt3 Activation Reverses Aging of Blood Stem Cells

Feb. 5, 2013
By Anette Breindl
Stem cells are supposed to be the fountain of youth for other tissues. But stem cells themselves age, too, meaning that sooner or later, the fountain of youth could use some rejuvenation itself.
Read More

'Support Cells' Star in Lack of Sleep's Antidepressant Effects

Feb. 4, 2013
By Anette Breindl
"For much of the 1900s, we studied neurons" to understand brain function, Philip Haydon told BioWorld Today. "And the reasons were purely technical. . . . We could listen to neurons, and we could talk to them." Neurons communicate electrically, and electrical recording and stimulation techniques made them amenable to studying. But in terms of what goes on in the brain, looking only at neurons is bound to deliver a minority report.
Read More

Peptide Encourages Cells to Eat Their Trash, and Viruses

Jan. 31, 2013
By Anette Breindl
Autophagy, Beth Levine told BioWorld Today, "can very simply be understood as a cellular housekeeping mechanism." But that simplicity is deceptive. Autophagy's housekeeping, it turns out, sits at a crossroads that gives it a role in many diseases.
Read More

Empty-Handed Delivery Man Nevertheless Fights Cancer

Jan. 30, 2013
By Anette Breindl
Researchers have used a gold-based nanoparticle that mimics high-density lipoprotein, or HDL, to kill lymphoma cells.
Read More

Biomarker of Aging Renders Early Stage Cancers Visible

Jan. 28, 2013
By Anette Breindl
Researchers have created a mouse with a reporter gene that appears to light up at the earliest stages of tumor development, regardless of the tissue type in which the tumor is developing.
Read More

BRCA Mutations Can be Found Without Sequencing Genes

Jan. 28, 2013
By Anette Breindl
Mutations in the genes for BRCA1 and BRCA2 were the first mutations identified that could predict an increased risk of cancer for their carriers. Some of them remain the strongest predictors of such increased risk – carriers of certain mutations have a 75 percent lifetime risk of developing breast or ovarian cancer.
Read More

Post-Discussion, Scientists End Voluntary Avian Flu Moratorium

Jan. 24, 2013
By Anette Breindl
Leading influenza researchers published a letter in the Jan. 24 and 25, 2013, issues of Nature and Science, respectively, declaring an end to a voluntary moratorium on research about how the H5N1 avian influenza could become easily transmissible from person to person, though with a notable exception: "Scientists should not restart their work in countries where, as yet, no decision has been reached on the conditions for H5N1 virus transmission research," they wrote in their letter.
Read More

Gut Microbes, Sex Hormones, Autoimmune Risk Interrelated

Jan. 23, 2013
By Anette Breindl
Autoimmune diseases are one area where it's a man's world. "Many autoimmune diseases are much more frequent in females," Jayne Danska told BioWorld Today. "That's been known for decades. But we don't have any insight into how to take that insight and do something useful for women with it."
Read More

DNA Donor Anonymity: for the Lucky Few?

Jan. 17, 2013
By Anette Breindl
Privacy concerns related to DNA sequencing got yet another airing today when a team from the Whitehead Institute reported in Science that using only publicly available information, they have been able to identify about 50 men who had anonymously donated DNA to projects such as the Thousand Genomes Project. While research subjects and sperm donors by and large want anonymity, others use DNA to find their relatives on the Internet, on sites like Y Search and the Sorenson Molecular Genealogy Foundation. In other words, there is plenty of DNA out there that has an identity attached to it. And if...
Read More
Previous 1 2 … 226 227 228 229 230 231 232 233 234 … 399 400 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 31, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 31, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing